Literature DB >> 17608733

The morphogenic function of E-cadherin-mediated adherens junctions in epithelial ovarian carcinoma formation and progression.

Colleen Wu1, Jane Cipollone, Sarah Maines-Bandiera, Clara Tan, Aly Karsan, Nelly Auersperg, Calvin D Roskelley.   

Abstract

E-cadherin expression is unusually regulated in epithelial ovarian carcinoma. It is not expressed in poorly cohesive ovarian surface epithelial (OSE) target cells, but is expressed in cohesive pre-malignant lesions and in highly cohesive, well-differentiated tumors where it is membrane associated, presumably in adherens junctions. E-cadherin expression is subsequently suppressed, or its function is disrupted, in late-stage invasive tumors. Here, we observed that increased E-cadherin expression in ovarian carcinoma cells was associated with increased E-cadherin promoter activity, increased adherens junction formation, decreased beta-catenin signaling-dependent LEF-1 activity, and the generation of cohesive spheroids in basement membrane gel culture. Forced expression of wild-type E-cadherin in immortalized OSE cells initiated adherens junction formation, decreased LEF-1 activity, decreased the mesenchymal migration that is a characteristic of OSE cells that have been maintained in monolayer culture, and induced the formation of cohesive spheroids in basement membrane gels. Conversely, forced expression of a dominant-negative E-cadherin mutant in ovarian carcinoma cells disrupted adherens junctions, increased mesenchymal cell migration, and prevented spheroidal morphogenesis without altering LEF-1 signaling. Therefore, in addition to suppressing late-stage tumor progression, E-cadherin-mediated adherens junctions may also contribute to the initial emergence of a cohesive morphogenic phenotype that is a hallmark of differentiated epithelial ovarian carcinoma.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17608733     DOI: 10.1111/j.1432-0436.2007.00193.x

Source DB:  PubMed          Journal:  Differentiation        ISSN: 0301-4681            Impact factor:   3.880


  24 in total

1.  Adhesion molecule protein signature in ovarian cancer effusions is prognostic of patient outcome.

Authors:  Geoffrey Kim; Ben Davidson; Ryan Henning; Junbai Wang; Minshu Yu; Christina Annunziata; Thea Hetland; Elise C Kohn
Journal:  Cancer       Date:  2011-08-25       Impact factor: 6.860

2.  The cadherin switch in ovarian high-grade serous carcinoma is associated with disease progression.

Authors:  Livia Quattrocchi; Andrew R Green; Stewart Martin; Lindy Durrant; Suha Deen
Journal:  Virchows Arch       Date:  2011-04-21       Impact factor: 4.064

3.  MUC16 mucin (CA125) regulates the formation of multicellular aggregates by altering β-catenin signaling.

Authors:  Panagiota Giannakouros; Marina Comamala; Isabelle Matte; Claudine Rancourt; Alain Piché
Journal:  Am J Cancer Res       Date:  2014-12-15       Impact factor: 6.166

Review 4.  Cadherin-mediated cell-cell interactions in normal and cancer cells.

Authors:  Natalya A Gloushankova; Svetlana N Rubtsova; Irina Y Zhitnyak
Journal:  Tissue Barriers       Date:  2017-07-20

5.  Hydrogen peroxide mediates EGF-induced down-regulation of E-cadherin expression via p38 MAPK and snail in human ovarian cancer cells.

Authors:  Jung-Chien Cheng; Christian Klausen; Peter C K Leung
Journal:  Mol Endocrinol       Date:  2010-07-07

6.  Hedgehog signaling pathway and ovarian cancer.

Authors:  Qi Chen; Guolan Gao; Shiwen Luo
Journal:  Chin J Cancer Res       Date:  2013-06       Impact factor: 5.087

7.  Primary peritoneal serous carcinoma: a clinicopathological and immunohistochemical study of six cases.

Authors:  Teng Hou; Dongxia Liang; Jiehua He; Xu Chen; Yanna Zhang
Journal:  Int J Clin Exp Pathol       Date:  2012-10-01

8.  Regulation of cell-cell contact molecules and the metastatic phenotype of medullary thyroid carcinoma by the Raf-1/MEK/ERK pathway.

Authors:  Li Ning; Muthusamy Kunnimalaiyaan; Herbert Chen
Journal:  Surgery       Date:  2008-12       Impact factor: 3.982

9.  Integrin beta3 down-regulates invasive features of ovarian cancer cells in SKOV3 cell subclones.

Authors:  Jie Chen; Jie Zhang; Yaoran Zhao; Jun Li; Maosun Fu
Journal:  J Cancer Res Clin Oncol       Date:  2008-12-23       Impact factor: 4.553

10.  Regulation of miR-200 family microRNAs and ZEB transcription factors in ovarian cancer: evidence supporting a mesothelial-to-epithelial transition.

Authors:  Ausra Bendoraite; Emily C Knouf; Kavita S Garg; Rachael K Parkin; Evan M Kroh; Kathy C O'Briant; Aviva P Ventura; Andrew K Godwin; Beth Y Karlan; Charles W Drescher; Nicole Urban; Beatrice S Knudsen; Muneesh Tewari
Journal:  Gynecol Oncol       Date:  2009-10-24       Impact factor: 5.482

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.